| LGSOC | Low-Grade Serous Ovarian Cancer |
| HGSOC | High-Grade Serous Ovarian Cancer |
| ORR | Overall response rate |
| FAK | Focal Adhesion Kinase |
| FAKi | Focal Adhesion Kinase Inhibitor |
| PDX | Patient-Derived Xenograft |
| OS | Overall Survival |
| IC | Confidence Interval |
| LGSOC | Low-Grade Serous Ovarian Cancer |
| HGSOC | High-Grade Serous Ovarian Cancer |
| ORR | Overall response rate |
| FAK | Focal Adhesion Kinase |
| FAKi | Focal Adhesion Kinase Inhibitor |
| PDX | Patient-Derived Xenograft |
| OS | Overall Survival |
| IC | Confidence Interval |